help button home button The Oncologist http://theoncologist.alphamedpress.org/misc/eLetters.shtml
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
A Role for Curative Surgery in the Treatment of Selected Patients with Meta...
Right arrow eLetters: Submit a response to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singletary, S. E.
Right arrow Articles by Hortobágyi, G. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singletary, S. E.
Right arrow Articles by Hortobágyi, G. N.
The Oncologist, Vol. 8, No. 3, 241–251, June 2003
© 2003 AlphaMed Press


ORIGINAL PAPER
Breast Cancer

A Role for Curative Surgery in the Treatment of Selected Patients with Metastatic Breast Cancer

S. Eva Singletarya, Garrett Walshb, Jean-Nicolas Vautheya, Steven Curleya, Raymond Sawayac, Kristin L. Webera, Funda Merica, Gabriel N. Hortobágyid

a Departments of Surgical Oncology, b Thoracic and Cardiovascular Surgery, c Neurosurgery, and d Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Correspondence: S. Eva Singletary, M.D., FACS, Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 444, Houston, Texas 77030-4095, USA. Telephone: 713-792-6937; Fax: 713-792-2225; e-mail: esinglet{at}mdanderson.org

Although metastatic breast cancer is widely believed to carry a grim prognosis, treatment developments over the past 25 years have greatly improved survival outcomes in these patients. In selected cases, aggressive treatment approaches may occasionally result in long-term survival of 15 years or more. This review considers the role of surgery in the treatment of single or multiple metastatic lesions restricted to one site. For each site, available literature from 1992–2002 was assessed to determine the role of surgery on survival outcomes and to determine appropriate criteria for selecting the best candidates for surgery. For lung, liver, brain, and sternum metastases, the use of surgery with or without adjuvant therapy resulted in greater median survival times and 5-year survival rates. The best candidate for surgery had no evidence of additional metastatic disease, good performance status, and a long disease-free interval after treatment of the primary tumor. Current treatment standards for breast cancer follow-up do not include imaging studies other than mammography. The addition of chest x-rays as part of routine follow-up should be considered as a cost-effective approach for early assessment of metastases to the lung or sternum that may be appropriate for surgical excision.

Key Words. Breast cancer • Metastasis • Surgery • Median survival




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
R. C. Fields, D. B. Jeffe, K. Trinkaus, Q. Zhang, C. Arthur, R. Aft, J. R. Dietz, T. J. Eberlein, W. E. Gillanders, and J. A. Margenthaler
Surgical Resection of the Primary Tumor is Associated with Increased Long-Term Survival in Patients with Stage IV Breast Cancer after Controlling for Site of Metastasis
Ann. Surg. Oncol., December 1, 2007; 14(12): 3345 - 3351.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
J. Gnerlich, D. B. Jeffe, A. D. Deshpande, C. Beers, C. Zander, and J. A. Margenthaler
Surgical Removal of the Primary Tumor Increases Overall Survival in Patients With Metastatic Breast Cancer: Analysis of the 1988 2003 SEER Data
Ann. Surg. Oncol., August 1, 2007; 14(8): 2187 - 2194.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. Rapiti, H. M. Verkooijen, G. Vlastos, G. Fioretta, I. Neyroud-Caspar, A. P. Sappino, P. O. Chappuis, and C. Bouchardy
Complete Excision of Primary Breast Tumor Improves Survival of Patients With Metastatic Breast Cancer at Diagnosis
J. Clin. Oncol., June 20, 2006; 24(18): 2743 - 2749.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
G. V. Babiera, R. Rao, L. Feng, F. Meric-Bernstam, H. M. Kuerer, S. E. Singletary, K. K. Hunt, M. I. Ross, K. M. Gwyn, B. W. Feig, et al.
Effect of Primary Tumor Extirpation in Breast Cancer Patients Who Present With Stage IV Disease and an Intact Primary Tumor
Ann. Surg. Oncol., June 1, 2006; 13(6): 776 - 782.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
G. Vlastos, D. L. Smith, S. E. Singletary, N. Q. Mirza, T. M. Tuttle, R. J. Popat, S. A. Curley, L. M. Ellis, M. S. Roh, and J.-N. Vauthey
Long-term Survival After An Aggressive Surgical Approach in Patients With Breast Cancer Hepatic Metastases
Ann. Surg. Oncol., September 1, 2004; 11(9): 869 - 874.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS
http://theoncologist.alphamedpress.org/subscriptions/etoc.dtl

Copyright © 2003 by AlphaMed Press.